IT-CHEM Co., Ltd.

아이티켐309710KOSDAQSector: Pharma & Biotech

₩21,0000.00%Market cap ₩268.4BAs of Sep 2, 2026 close · updated once daily

Market cap

₩268.4B

#299 in KOSDAQ

Loss

PER not computable

4.11x

Sector median 1.61x

0.0%

Sector median 0.0%

Trading halted — grade display suspended

This stock is under a trading halt per KRX disclosure. Grade display resumes once trading resumes.

See withholding criteria →View source filing (DART) ↗

This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

1-year closing price

Low ₩17,620High ₩49,700

Latest close

Price change by period

0.00%

10.60%

As of the Sep 2, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

26.5/100

How much debt does it carry relative to equity?

177.3%

Sector median 51.6%

Sector low

highBottom 11.1% in sector

Can it cover what's due within a year?

66.5%

Sector median 191.7%

Sector low

highBottom 13.2% in sector

How much of revenue becomes profit?

-3.0%

Sector median -2.4%

Sector low

highBottom 49% in sector

How much did it earn on its own capital?

-21.9%

Sector median -4.5%

Sector low

highBottom 32.6% in sector

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

31.6/100

Is the price expensive relative to earnings?

Loss-making (P/E not computable)

Sector median P/E of profitable peers 16.3x · 58% loss-making

Sector low

highBottom 35% in sector

Is the price expensive relative to book value?

4.11x

Sector median 1.61x

Sector low

highBottom 28.1% in sector

Valuation uses the Sep 2, 2026 close and market cap

Shareholder Return

Single-indicator axis37.5/100

Does the company actually pay dividends?

0.0%

Sector median 0.0%

Sector low

highBottom 37.5% in sector

Dividends & treasury shares

Treasury shares (FY2025): 288,015 shares (2.2% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 1 met · 2 not met · 6 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Not met

-₩14.3B

Positive operating cash flow

Whether cash flow from operations is above zero.

Not met

-₩1.7B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Not computable

Not computed — required financial data is unavailable

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Met

-₩1.7B vs -₩14.3B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Not computable

Not computed — required financial data is unavailable

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Not computable

Not computed — required financial data is unavailable

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Not computable

Not computed — share count data is unavailable

Operating margin up

Whether operating income over revenue rose from the prior year.

Not computable

Not computed — required financial data is unavailable

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Not computable

Not computed — required financial data is unavailable

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026D

Methodology version change (v2.0 applied)

Jul 15, 2026DVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

CB with conversion-price adjustment clause (past 36 months)

1 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2026-02-19). View filing ↗

Largest-shareholder changes (past 36 months)

The largest shareholder changed 8 times in the past 36 months (latest change 2025-12-30, per annual report).

Determined as of 2026-09-02

Recent filings for this stock

Last 120 days · monitored filing types only

Periodic report filedAug 28, 2026Source ↗

Periodic report filedJun 1, 2026Source ↗

View in the filings calendar →